Advances in Gerontology

, Volume 2, Issue 1, pp 60–64 | Cite as

The effects of IL-6 cytokine expression in renal tissue on the clinical and morphological picture of IgA-nephropathy in patients over 60 years old

  • T. S. Ryabova
  • I. A. Rakityanskaya


In this paper, the expression of IL-6 cytokine in kidney biopsy tissue of IgA-nephropathy patients of different age groups was analyzed and its correlation with the clinical and morphological picture of the disease was investigated. In the study it was shown that IL-6 affects the formation of histopathological changes of kidney tissue and this process has no dependence on the patient’s age. Given that the duration of the disease influences the level of IL-6 expression in the glomerulus regardless of the patient’s age, the role of IL-6 in the disease development was confirmed.


IgA-nephropathy interleukin-6 biopsy tissue age 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rakityanskaya, I.A., Immunopathogenetic Mechanisms of Development and Progress Glomerulonephritis, in Nefrologiya: Ruk. dlya vrachei (Nephrology: Manual for Doctors), Ryabov, S.I., Ed., St. Petersburg: Spetslit, 2000, pp. 37–69.Google Scholar
  2. 2.
    Ryabov, S.I. and Rakityanskaya, I.A., Role Mononuklears in Nephron in Patients with Chronic Glomerulonephritis, Message II: Role of Interleukines (IL-6 and IL-10) and Proliferation of Glomerular and Interstitial Cellsof Nephron at Development of Mesangium-Proliferative Glomerulonephritis, Nefrologiya, 1998, vol. 2, no. 2, pp. 30–36.Google Scholar
  3. 3.
    Anders, H.-J., Banas, B., and Schlöndorff, D., Signaling Danger: Toll-Like Receptors and Their Potential Roles in Kidney Disease, J. Amer. Soc. Nephrol., 2004, vol. 15, pp. 854–867.CrossRefGoogle Scholar
  4. 4.
    Bantis, C., Heering, P., Aker, S., et al., Influence of Cytokine Gene Polymorphisms on IgA Nephropathy, Ren Fail., 2008, vol. 30, no. 2, pp. 135–140.CrossRefGoogle Scholar
  5. 5.
    Boswell, R.N., Yard, B.A., Schrama, E., et al., Interleukin 6 Production by Human Proximal Tubular Epithelial Cells in Vitro: Analysis of the Effects of Interleukin-1 Alpha (IL-1 Alpha) and Other Cytokines, Nephrol. Dial Transplant., 1994, vol. 9, no. 6, pp. 599–606.PubMedGoogle Scholar
  6. 6.
    Bruunsgaard, H., Pedersen, M., and Pedersen, B.K., Aging and Proinflammatory Cytokines, Curr. Opin. Hemat., 2001, vol. 8, no. 3, pp. 131–136.CrossRefGoogle Scholar
  7. 7.
    Buraczynska, M., Jozwiak, L., Ksiazek, P., et al., Interleukin-6 Gene Polymorphism and Faster Progression to End-Stage Renal Failure in Chronic Glomerulonephritis, Transplant. Res. 2007, vol. 150, no. 2, pp. 101–105.Google Scholar
  8. 8.
    De Martinis, M., Franceschi, C., Monti, D., and Ginaldi, L., Inflammageing and Lifelong Antigenic Load as Major Determinants of Aging Rate and Longevity, FEBS Lett., 2005, vol. 579, pp. 2035–2039.PubMedCrossRefGoogle Scholar
  9. 9.
    Fonseca, J. E., Santos, M. J., Canhão, H., and Choy, E., Interleukin-6 as a Key Player in Systemic Inflammation and Joint Destruction, Autoimmun. Rev., 2009, vol. 8, no. 7, pp. 538–542.PubMedCrossRefGoogle Scholar
  10. 10.
    Haradaa, K., Akaia, Y., Kurumatani, N., et al., Prognostic Value of Urinary Interleukin 6 in Patients with IgA Nephropathy: An 8-Year Follow-Up Study, Nephron., 2002, vol. 92, no. 4, pp. 824–826.CrossRefGoogle Scholar
  11. 11.
    Kawai T. and Akira, S., TLR Signaling, Seminars Immunol., 2007, vol. 19, pp. 24–32.CrossRefGoogle Scholar
  12. 12.
    Leonard, M., Ryan, M.P., Watson, A.J., et al., Role of MAP Kinase Pathways in Mediating IL-6 Production in Human Primary Mesangial and Proximal Tubular Cells, Kidn. Int., 1999, vol. 56, no. 4, pp. 1366–1377.CrossRefGoogle Scholar
  13. 13.
    Licastro, F., Candore, G., Lio, D., et al., Innate Immunity and Inflammation in Ageing: A Key for Understanding Age-Related Diseases, Immunol. Aging, 2005, vol. 2, p. 8.CrossRefGoogle Scholar
  14. 14.
    Lim, C.S., Kim, Y.S., Ahn, C.R., et al., Intrarenal Expression of Interleukin-6 and the -174 G/C Polymorphism in IgA Nephropathy, Korean J. Nephrol., 2002, vol. 21, no. 4, pp. 595–601.Google Scholar
  15. 15.
    Maksić, D.J., Dimitrijević, J., Spasić, P., et al., Correlation of Inflammatory Cytokines in the Urine and Serum with Clinico-Laboratory and Pathohistologic Features in Patients with IgA Nephropathy, Srp. Arh. Celok Lek., 1996, vol. 124, suppl. 1, pp. 37–40.PubMedGoogle Scholar
  16. 16.
    Noronha, I.L., Niemir, Z., Stein, H., and Waldherr, R., Cytokines and Growth Factors in Renal Disease, Nephrol. Dial. Transplant., 1995, vol. 10, no. 6, pp. 775–786.PubMedGoogle Scholar
  17. 17.
    O’Neill, L.A. and Bowie, A.G., The Family of Five: TIR-Domain-Containing Adaptors in Toll-Like Receptor Signaling, Nat. Rev. Immunol., 2007, vol. 7, no. 5, pp. 353–364.PubMedCrossRefGoogle Scholar
  18. 18.
    Rostoker, G., Rymer, J.-C., Bagnard, G., et al., Imbalances in Serum Proinflammatory Cytokines and Their Soluble Receptors: A Putative Role in the Progression of Idiopathic IgA Nephropathy (IgAN) and Henoch-Schönlein Purpura Nephritis, and a Potential Target of Immunoglobulin Therapy? Clin. Exp. Immunol., 1998, vol. 114, no. 3, pp. 468–476.PubMedCrossRefGoogle Scholar
  19. 19.
    Ruef, C., Budde, K., Lacy, J., et al., Interleukin 6 is an Autocrine Growth Factor for Mesangial Cells, Kidn. Int., 1990, vol. 38, no. 2, pp. 249–57.CrossRefGoogle Scholar
  20. 20.
    Schena, F.P., Gesualdo, L., Grandaliano, G., and Montinaro, V., Progression of Renal Damage in Human Glomerulonephritides: Is There Sleight of Hand in Winning the Game? Kidn. Int., 1997, vol. 52, pp. 1439–1457.CrossRefGoogle Scholar
  21. 21.
    Smith, K.D., Lipchock, S.V., Ames, T.D., et al., Structural Basis of Ligand Binding by a C-Di-GMP Riboswitch, Nat. Struct. Mol. Biol., 2009, vol. 16, no. 12, pp. 1218–1223.PubMedCrossRefGoogle Scholar
  22. 22.
    Sterzel, R.B., Schulze-Lohoff, E., and Marx, M., Cytokines and Mesangial Cells, Kidn. Int., 1993, vol. 39, pp. 26–31.Google Scholar
  23. 23.
    Taniguchi, Y., Yorioka, N., Oda, H., Yamakido, M., Platelet-Derived Growth Factor, Interleukin (IL)-1 Beta, IL-6R and Tumor Necrosis Factor-Alpha in IgA Nephropathy: An Immunohistochemical Study, Nephron, 1996, vol. 74, no. 4, pp. 652–660.PubMedCrossRefGoogle Scholar
  24. 24.
    Van den Biggelaar, A.H., Huizinga, T.W., De Craen, A.J., et al., Impaired Innate Immunity Predicts Frailty in Old Age. The Leiden 85-Plus Study, Exp. Geront., 2004, vol. 39, pp. 1407–1414.CrossRefGoogle Scholar
  25. 25.
    Wadaa, J., Sugiyamaa, H., Makino, H., Pathogenesis of IgA Nephropathy, Seminars Nephrol., 2003, no. 6, pp. 556–563.Google Scholar
  26. 26.
    Wagner, H., The Immunobiology of the TLR9 Subfamily, Trends Immunol., 2004, vol. 25, pp. 381–386.PubMedCrossRefGoogle Scholar
  27. 27.
    Yano, N., Endoh, M., Nomoto, Y., et al., Phenotypic Characterization of Cytokine Expression in Patients with IgA Nephropathy, J. Clin. Immunol., 1997, vol. 17, no. 5, pp. 396–403.PubMedCrossRefGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2012

Authors and Affiliations

  1. 1.Hospital of Holy Martyr GeorgeSt. PetersburgRussia

Personalised recommendations